These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 37410304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The clinical features of Fournier's gangrene and the predictivity of the Fournier's Gangrene Severity Index on the outcomes.
    Kabay S, Yucel M, Yaylak F, Algin MC, Hacioglu A, Kabay B, Muslumanoglu AY.
    Int Urol Nephrol; 2008; 40(4):997-1004. PubMed ID: 18563618
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Overview of different scoring systems in Fournier's Gangrene and assessment of prognostic factors.
    Doluoğlu ÖG, Karagöz MA, Kılınç MF, Karakan T, Yücetürk CN, Sarıcı H, Özgür BC, Eroğlu M.
    Turk J Urol; 2016 Sep; 42(3):190-6. PubMed ID: 27635295
    [Abstract] [Full Text] [Related]

  • 11. Fournier's gangrene: overview of prognostic factors and definition of new prognostic parameter.
    Erol B, Tuncel A, Hanci V, Tokgoz H, Yildiz A, Akduman B, Kargi E, Mungan A.
    Urology; 2010 May; 75(5):1193-8. PubMed ID: 20451745
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the newly developed Fournier's gangrene mortality prediction model with existing models.
    Çomçalı B, Ceylan C, Altun Özdemir B, Ağaçkıran İ, Akıncı F.
    Ulus Travma Acil Cerrahi Derg; 2022 Apr; 28(4):490-497. PubMed ID: 35485517
    [Abstract] [Full Text] [Related]

  • 16. The role of C-reactive protein albumin ratio for predicting mortality in patients with Fournier's gangrene.
    Özgül H, Uzmay Y.
    Ulus Travma Acil Cerrahi Derg; 2023 Oct 27; 29(11):1242-1247. PubMed ID: 37889021
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Validation and simplification of Fournier's gangrene severity index.
    Lin TY, Ou CH, Tzai TS, Tong YC, Chang CC, Cheng HL, Yang WH, Lin YM.
    Int J Urol; 2014 Jul 27; 21(7):696-701. PubMed ID: 24635453
    [Abstract] [Full Text] [Related]

  • 20. Lymphocyte-to-C-reactive protein ratio as a new biomarker for predicting mortality and morbidity in Fournier's gangrene.
    Yildirim M, Gul SC, Angın YS, Saglam AI, Ozsoy U, Koca B, Ozkan N.
    Cir Cir; 2024 Jul 27; 92(2):181-188. PubMed ID: 38782374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.